STAT3 Differentially Regulates TLR4-Mediated Inflammatory Responses in Early or Late Phases

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Toll-like receptor 4 (TLR4) signaling is crucial for managing lipopolysaccharide (LPS)-induced inflammation.
• Signal transducer and activator of transcription 3 (STAT3) is a key regulator in immune responses and a potential therapeutic target.

Purpose of the Study:

• To investigate the time-dependent functions of STAT3 in LPS-stimulated RAW264.7 macrophages.
• To elucidate the molecular mechanisms underlying STAT3's role in TLR4-mediated inflammation.

Main Methods:

• Utilized STAT3 inhibition and knockout strategies in RAW264.7 macrophages stimulated with LPS.
• Analyzed the expression of pro-inflammatory genes (iNOS, COX-2) and signaling pathways (NF-κB, Akt/PI3K).
• Investigated the phosphorylation of Lyn kinase and nuclear translocation of NF-κB subunits.

Main Results:

• STAT3 inhibition at early time points increased iNOS and COX-2 expression.
• STAT3 depletion affected NF-κB and Akt/PI3K signaling, including nuclear translocation of NF-κB p50/p65.
• Lyn kinase was phosphorylated in STAT3 knockout macrophages.
• Pharmacological inhibition of NF-κB and Akt suppressed iNOS and COX-2 expression during early LPS stimulation.
• Prolonged LPS treatment led to downregulated iNOS expression, suppressed NF-κB activation, and reduced nitric oxide production and cell invasion.

Conclusions:

• STAT3 differentially regulates early- and late-phase TLR4-mediated inflammatory responses.
• An NF-κB-Akt-dependent mechanism is involved in STAT3's regulation of early inflammatory gene expression.
• STAT3 plays a complex, time-dependent role in modulating macrophage inflammatory responses to LPS.